Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOSOTO: Sotorasib, Panitumumab, and 5-FU in Advanced KRAS G12C Colorectal Cancer
NCT07124884Phase 2Not yet recruiting
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Aug 2025
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of sotorasib in colorectal cancer (CRC), sponsored by Fédération Francophone de Cancérologie Digestive. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
sotorasib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07124884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07124884.